Clinical Diagnostics Technology & Disease Research News | 360Dx
网页The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026. Congress Passes One-Year Delay to PAMA Implementation …. Again. Lab test reimbursement cuts and price reporting requirements that were called for under the law will be delayed as part of the recently ...
WHO Approves Abbott Molecular Mpox Assay | 360Dx
网页22 小时之前 — WHO Approves Abbott Molecular Mpox Assay. NEW YORK – The World Health Organization on Thursday announced that Abbott's Alinity M MPXV assay has been listed under the agency's Emergency Use Listing (EUL) procedure. The real-time PCR test detects monkeypox virus DNA from human skin lesion swabs and is designed for use by trained clinical ...
After Series A Financing, Digital Pathology Firm PathPresenter …
网页22 小时之前 — NEW YORK – Digital pathology firm PathPresenter originally began in 2017 as a way for pathologists to share slides with colleagues, but after several years of expansion and a $7.5 million Series A financing round that closed last month, the firm has grown to encompass education, clinical, and research applications.. Cofounder Rajendra Singh was a pathologist who wanted an easy way to share ...
360Dx Top 30 Inches up 1 Percent in September | 360Dx
网页2 天之前 — Quanterix has been added in its place. NEW YORK – The 360Dx Top 30 inched up another 1 percent in September after a month-over-month 2 percent jump in August. The Top 30 matched or bettered the broader market as the Dow Jones Industrial Average rose 2 percent and the Nasdaq increased 3 percent. In contrast, the Nasdaq Biotech Index declined 2 ...
About Us - 360Dx
网页About Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
Top Five Articles on 360Dx Last Week: Digital Pathology Adoption; …
网页3 天之前 — NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) As Digital Pathology Slowly Expands, Industry Anxiously Awaits a Breakout Moment 2) FDA to Reclassify Hepatitis B Virus Tests as Moderate Risk Devices 3) Bio-Rad Laboratories, Sysmex America Partner for QC Software 4) Fujirebio Files Blood-Based Alzheimer's Test With FDA
Breaking News - 360Dx
网页2024年9月27日 — Texas Lab Owner Indicted for COVID-19 Fraud Scheme. According to the government, Rashid Naqvi, a Houston-area resident, fraudulently sought $4.6 million from Medicare for COVID-19 test kits and obtained $2.0 million. Sep 26, 2024.
coronavirus Diagnostics News | 360Dx
网页coronavirus. Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.
360Dx Top 30 Slides 1 Percent in January
网页2024年2月1日 — 360Dx Top 30 Slides 1 Percent in January. Note: The 360Dx Top 30 has been updated with new entries Biodesix, MDxHealth, OraSure Technologies, and Sera Prognostics based on market cap as of beginning of trading in January 2024. LumiraDx was removed due to the acquisition of most of its assets by Roche, and Accelerate Diagnostics, Burning Rock ...
Coronavirus Test Tracker: Commercially Available COVID-19 ... - 360Dx
网页As labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets. The tracker includes only those tests that ...